Tvardi Therapeutics

Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum

Houston, Texas. November 12, 2020 – Tvardi Therapeutics (“Tvardi”), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, was recognized as one of the 10 Most Promising Life Science Companies at the 2020 Texas Life Science Forum. Hosted by BioHouston and the Rice Alliance, the 2020 Texas Life Science Forum is …

Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum Read More »